ITMI20050909A1 - Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2- - Google Patents

Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-

Info

Publication number
ITMI20050909A1
ITMI20050909A1 IT000909A ITMI20050909A ITMI20050909A1 IT MI20050909 A1 ITMI20050909 A1 IT MI20050909A1 IT 000909 A IT000909 A IT 000909A IT MI20050909 A ITMI20050909 A IT MI20050909A IT MI20050909 A1 ITMI20050909 A1 IT MI20050909A1
Authority
IT
Italy
Prior art keywords
production
prostaglandina
benzoil
pge2
carbazole
Prior art date
Application number
IT000909A
Other languages
English (en)
Italian (it)
Inventor
Maria Alessandra Alisi
Nicola Cazzolla
Isabella Coletta
Guido Furlotti
Giorgina Mangano
Caterina Maugeri
Lorenzo Polenzani
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Priority to IT000909A priority Critical patent/ITMI20050909A1/it
Priority to DE602006015457T priority patent/DE602006015457D1/de
Priority to KR1020077029661A priority patent/KR101312579B1/ko
Priority to PT06753538T priority patent/PT1881826E/pt
Priority to AU2006246688A priority patent/AU2006246688B2/en
Priority to US11/909,393 priority patent/US8686021B2/en
Priority to EP06753538A priority patent/EP1881826B1/en
Priority to PL06753538T priority patent/PL1881826T3/pl
Priority to ES06753538T priority patent/ES2347174T3/es
Priority to JP2008511591A priority patent/JP5086991B2/ja
Priority to EA200702534A priority patent/EA012724B1/ru
Priority to AT06753538T priority patent/ATE473739T1/de
Priority to GEAP200610441A priority patent/GEP20094738B/en
Priority to SI200630781T priority patent/SI1881826T1/sl
Priority to UAA200713598A priority patent/UA94044C2/ru
Priority to PCT/EP2006/004348 priority patent/WO2006122680A1/en
Priority to BRPI0609718-9A priority patent/BRPI0609718A2/pt
Priority to DK06753538.5T priority patent/DK1881826T3/da
Priority to CA2604562A priority patent/CA2604562C/en
Priority to MX2007013491A priority patent/MX2007013491A/es
Priority to CN2006800144162A priority patent/CN101166528B/zh
Priority to HK08111668.0A priority patent/HK1119571B/xx
Priority to ARP060101981A priority patent/AR054126A1/es
Publication of ITMI20050909A1 publication Critical patent/ITMI20050909A1/it
Priority to IL186072A priority patent/IL186072A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IT000909A 2005-05-19 2005-05-19 Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2- ITMI20050909A1 (it)

Priority Applications (24)

Application Number Priority Date Filing Date Title
IT000909A ITMI20050909A1 (it) 2005-05-19 2005-05-19 Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-
GEAP200610441A GEP20094738B (en) 2005-05-19 2006-05-03 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
AT06753538T ATE473739T1 (de) 2005-05-19 2006-05-03 Verwendung eines benzoyl-derivats von 3- aminocarbazol zur behandlung einer erkrankung im zusammenhang mit der erzeugung von prostaglandin e2 (pge2)
PT06753538T PT1881826E (pt) 2005-05-19 2006-05-03 Utilização de um derivado benzoil de 3-aminocarbazol para o tratamento de uma doença associada com a produção de prostaglandina e2 (pge2)
AU2006246688A AU2006246688B2 (en) 2005-05-19 2006-05-03 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin E2 (PGE2)
US11/909,393 US8686021B2 (en) 2005-05-19 2006-05-03 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin E2 (PGE2)
EP06753538A EP1881826B1 (en) 2005-05-19 2006-05-03 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
KR1020077029661A KR101312579B1 (ko) 2005-05-19 2006-05-03 프로스타글란딘 ｅ2의 생산과 관련된 질환 치료용3-아미노카보졸의 벤조일 유도체의 용도
ES06753538T ES2347174T3 (es) 2005-05-19 2006-05-03 Utilizacion de un derivado benzoilo 3-aminocarbazol para el tratamiento de un trastorno asociado a la produccion de la prostaglandina e2 (pge2).
JP2008511591A JP5086991B2 (ja) 2005-05-19 2006-05-03 プロスタグランジンｅ２（ｐｇｅ２）の生産に関連する障害の処置のための３−アミノカルバゾールのベンゾイル誘導体の使用
EA200702534A EA012724B1 (ru) 2005-05-19 2006-05-03 Применение бензоильного производного 3-аминокарбазола для лечения расстройства, связанного с продукцией простагландина e2 (pge2)
DE602006015457T DE602006015457D1 (de) 2005-05-19 2006-05-03 Verwendung eines benzoyl-derivats von 3-aminocarbazol zur behandlung einer erkrankung im zusammenhang mit der erzeugung von prostaglandin e2 (pge2)
PL06753538T PL1881826T3 (pl) 2005-05-19 2006-05-03 Zastosowanie benzoilowej pochodnej 3-aminokarbazolu do leczenia zaburzenia związanego z wytwarzaniem prostaglandyny E2 (PGE2)
DK06753538.5T DK1881826T3 (da) 2005-05-19 2006-05-03 Anvendelse af et benzoyl-derivat af 3-aminocarbazol til behandling af en forstyrrelse i forbindelse med produktionen af prostaglandin E2 (PGE2)
UAA200713598A UA94044C2 (ru) 2005-05-19 2006-05-03 Применение бензоильного производного 3-аминокарбазола для лечения нарушения, связанного с производством простагландина e2 (pge2)
PCT/EP2006/004348 WO2006122680A1 (en) 2005-05-19 2006-05-03 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
BRPI0609718-9A BRPI0609718A2 (pt) 2005-05-19 2006-05-03 uso de um composto, e, método para o tratamento preventivo ou terapêutico de um distúrbio
SI200630781T SI1881826T1 (sl) 2005-05-19 2006-05-03 Uporaba benzoil derivata 3-aminokarbazola za zdravljenje motnje, povezane s produkcijo prostaglandina E2 (PGE2)
CA2604562A CA2604562C (en) 2005-05-19 2006-05-03 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
MX2007013491A MX2007013491A (es) 2005-05-19 2006-05-03 Uso de un derivado de benzoilo de 3-aminocarbazol para el tratamiento de un trastorno asociado con la produccion de prostaglandina e2 (pge2).
CN2006800144162A CN101166528B (zh) 2005-05-19 2006-05-03 3-氨基咔唑的苯甲酰衍生物在制备治疗与前列腺素e2(pge2)的产生有关的疾病的药物中的应用
HK08111668.0A HK1119571B (en) 2005-05-19 2006-05-03 Use of a benzoyl derivative of 3-aminocarbazole in manufacture of a medicament in the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
ARP060101981A AR054126A1 (es) 2005-05-19 2006-05-17 Utilizacion de un benzoilderivado del 3-aminocarbazol para la produccion de un farmaco para el tratamiento de un desorden asociado a la produccion de prostaglandina e2 (pge2)
IL186072A IL186072A (en) 2005-05-19 2007-09-19 Use of a benzoyl derivative of 3-aminocarbazole for the production of a drug for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000909A ITMI20050909A1 (it) 2005-05-19 2005-05-19 Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-

Publications (1)

Publication Number Publication Date
ITMI20050909A1 true ITMI20050909A1 (it) 2006-11-20

Family

ID=35219704

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000909A ITMI20050909A1 (it) 2005-05-19 2005-05-19 Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-

Country Status (23)

Country Link
US (1) US8686021B2 (enExample)
EP (1) EP1881826B1 (enExample)
JP (1) JP5086991B2 (enExample)
KR (1) KR101312579B1 (enExample)
CN (1) CN101166528B (enExample)
AR (1) AR054126A1 (enExample)
AT (1) ATE473739T1 (enExample)
AU (1) AU2006246688B2 (enExample)
BR (1) BRPI0609718A2 (enExample)
CA (1) CA2604562C (enExample)
DE (1) DE602006015457D1 (enExample)
DK (1) DK1881826T3 (enExample)
EA (1) EA012724B1 (enExample)
ES (1) ES2347174T3 (enExample)
GE (1) GEP20094738B (enExample)
IL (1) IL186072A (enExample)
IT (1) ITMI20050909A1 (enExample)
MX (1) MX2007013491A (enExample)
PL (1) PL1881826T3 (enExample)
PT (1) PT1881826E (enExample)
SI (1) SI1881826T1 (enExample)
UA (1) UA94044C2 (enExample)
WO (1) WO2006122680A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20051523A1 (it) 2005-08-03 2007-02-04 Acraf Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
EP2119705A1 (en) 2008-05-14 2009-11-18 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor
US8880004B2 (en) 2009-05-14 2014-11-04 Qualcomm Incorporated System and method for resolving conflicts between air interfaces in a wireless communication system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
US6399631B1 (en) 1999-07-23 2002-06-04 Pfizer Inc. Carbazole neuropeptide Y5 antagonists
AU6000900A (en) 1999-07-23 2001-02-13 Astrazeneca Uk Limited Carbazole derivatives and their use as neuropeptide y5 receptor ligands
JP2003507424A (ja) * 1999-08-26 2003-02-25 ブリストル−マイヤーズ スクイブ カンパニー Ｎｐｙアンタゴニスト：スピロイソキノリノン誘導体
DE10125961A1 (de) 2001-05-29 2002-12-12 Boehringer Ingelheim Int Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden
CA2403307A1 (en) * 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
KR20030042344A (ko) * 2001-11-22 2003-05-28 한국생명공학연구원 에레모필란계 화합물 또는 곰취추출물을 유효성분으로함유하는 염증질환 치료제, 면역질환 치료제, 및 암 치료제
ES2193875B2 (es) * 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
KR100402714B1 (ko) * 2002-12-23 2003-11-13 한국생명공학연구원 디테르펜계 화합물을 염증질환, 면역질환 및 암 치료제로사용하는 신규한 용도

Also Published As

Publication number Publication date
CN101166528A (zh) 2008-04-23
EP1881826A1 (en) 2008-01-30
IL186072A0 (en) 2008-08-07
CA2604562C (en) 2013-09-17
IL186072A (en) 2012-05-31
ES2347174T3 (es) 2010-10-26
PT1881826E (pt) 2010-08-05
CN101166528B (zh) 2011-06-15
AU2006246688A1 (en) 2006-11-23
UA94044C2 (ru) 2011-04-11
JP2008540591A (ja) 2008-11-20
JP5086991B2 (ja) 2012-11-28
KR101312579B1 (ko) 2013-09-30
KR20080018898A (ko) 2008-02-28
SI1881826T1 (sl) 2010-10-29
WO2006122680A1 (en) 2006-11-23
GEP20094738B (en) 2009-07-27
MX2007013491A (es) 2008-01-24
PL1881826T3 (pl) 2010-12-31
CA2604562A1 (en) 2006-11-23
AR054126A1 (es) 2007-06-06
US20080287518A1 (en) 2008-11-20
BRPI0609718A2 (pt) 2011-10-18
EP1881826B1 (en) 2010-07-14
EA012724B1 (ru) 2009-12-30
DE602006015457D1 (de) 2010-08-26
HK1119571A1 (en) 2009-03-13
ATE473739T1 (de) 2010-07-15
EA200702534A1 (ru) 2008-04-28
AU2006246688B2 (en) 2011-09-22
US8686021B2 (en) 2014-04-01
DK1881826T3 (da) 2010-11-01

Similar Documents

Publication Publication Date Title
IL282138B1 (en) Process for preparing purified drug conjugates
HUS1200023I1 (hu) Eljárás vakcinák elõállítására
HUE061093T2 (hu) Eljárás katalitikus anyagok elõállítására
DK1795576T3 (da) Fremgangsmåde til fremstilling af carbonhydrider
DK1741768T4 (da) Fremgangsmåde til fremstilling af dieselcarbonhydrider
IL180252A0 (en) Intermediates for the preparation of halichondrin b
ZA200702487B (en) Production of anti-amyloid beta antibodies
EP1996710A4 (en) Rifaximin anti-rectal dysfunction preparation
DK1963369T3 (da) Il-21-antagonister
DE602005022650D1 (de) Verbessertes Plattierungsverfahren
ZA200708811B (en) Use of a sulfonamide compound for improving the pharma-cokinetics of a drug
FI20055616A0 (fi) Menetelmä valmisteen rakenteen muokkaamiseen
ITMI20052085A1 (it) Tutore ambidestro per polso provvisto di immobilizzatore del pollice
EP1940438A4 (en) STABILIZED GLP-1 ANALOGUES
ITMI20050909A1 (it) Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-
HUP0500537A3 (en) Process for the preparation of rosuvastatin via new intermediates
PL2234996T3 (pl) Sposób wytwarzania surowego trioksanu
ITMI20051826A1 (it) Kit per la somministrazione parenterale di medicamenti
ITUD20040054A1 (it) Procedimento per la realizzazione di un
HUP0501138A2 (en) Process for the production of a pharmaceutical intermediate
PL380727A1 (pl) Sposób wytwarzania saletrosiarczanu amonowego
FR2914219B1 (fr) Procede de moulage monolithique d'une piece creuse, piece creuse monolithique obtenue.
IL178772A0 (en) Process for the production of cyclic diketones
ITPD20070037A1 (it) Cassaforma per il getto di pilastri
FI20060957A0 (fi) Menetelmä induktiivisen komponenttien valmistamiseksi